PHR1080
Octinoxate
Pharmaceutical Secondary Standard; Certified Reference Material
Synonym(s):
2-Ethylhexyl 4-methoxycinnamate, 4-Methoxycinnamic acid 2-ethylhexyl ester, OMC, Octyl methoxycinnamate
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C18H26O3
CAS Number:
Molecular Weight:
290.40
Beilstein/REAXYS Number:
5946632
EC Number:
MDL number:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24
Recommended Products
grade
certified reference material
pharmaceutical secondary standard
Quality Level
agency
traceable to USP 1477900
API family
octinoxate
CofA
current certificate can be downloaded
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
CCCCC(CC)COC(=O)\C=C\c1ccc(OC)cc1
InChI
1S/C18H26O3/c1-4-6-7-15(5-2)14-21-18(19)13-10-16-8-11-17(20-3)12-9-16/h8-13,15H,4-7,14H2,1-3H3/b13-10+
InChI key
YBGZDTIWKVFICR-JLHYYAGUSA-N
Looking for similar products? Visit Product Comparison Guide
General description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Octinoxate belongs to a category of compounds called ‘organic UV-filters (UVFs)′ which constitute an active ingredient of a variety of products, such as cosmetics, sunscreens and lip balms.
Octinoxate belongs to a category of compounds called ‘organic UV-filters (UVFs)′ which constitute an active ingredient of a variety of products, such as cosmetics, sunscreens and lip balms.
Application
Octinoxate may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by chromatographic and spectrophotometric techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Analysis Note
These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
Other Notes
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
Footnote
To see an example of a Certificate of Analysis for this material enter LRAB3324 in the slot below. This is an example certificate only and may not be the lot that you receive.
Recommended products
Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.
related product
Product No.
Description
Pricing
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Current sunscreen issues: 2007 Food and Drug Administration sunscreen labelling recommendations and combination sunscreen/insect repellent products
Hexsel CL, et al.
Journal of the American Academy of Dermatology, 59(2), 316-323 (2008)
Ozonation of the oxybenzone, octinoxate, and octocrylene UV-filters: Reaction kinetics, absorbance characteristics, and transformation products
Hopkins ZR, et al.
Journal of Hazardous Materials, 338, 23-32 (2017)
Review of environmental effects of oxybenzone and other sunscreen active ingredients
Schneider SL and Lim HW
Journal of the American Academy of Dermatology, 80(1), 266-271 (2019)
Endocrine disruptors and asthma-associated chemicals in consumer products
Dodson RE, et al.
Environmental Health Perspectives, 120(7), 935-943 (2012)
Timothy P Murphy et al.
Journal of the American College of Cardiology, 65(10), 999-1009 (2015-03-15)
Treatment for claudication that is due to aortoiliac peripheral artery disease (PAD) often relies on stent revascularization (ST). However, supervised exercise (SE) is known to provide comparable short-term (6-month) improvements in functional status and quality of life. Longer-term outcomes are
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service